Onsdag 29 Oktober | 16:02:06 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-10-30 07:30 Kvartalsrapport 2026-Q3
2026-07-10 07:30 Kvartalsrapport 2026-Q2
2026-05-27 N/A Årsstämma
2026-04-30 07:30 Kvartalsrapport 2026-Q1
2026-02-06 07:30 Bokslutskommuniké 2025
2025-10-21 - Extra Bolagsstämma 2026
2025-10-20 - Kvartalsrapport 2025-Q3
2025-07-14 - Split QLINEA 1000:1
2025-07-10 - Kvartalsrapport 2025-Q2
2025-06-26 - Årsstämma
2025-05-23 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2025-04-14 - Kvartalsrapport 2025-Q1
2025-04-03 - Extra Bolagsstämma 2025
2025-02-28 - Bokslutskommuniké 2024
2024-11-05 - Kvartalsrapport 2024-Q3
2024-07-11 - Kvartalsrapport 2024-Q2
2024-06-28 - Årsstämma
2024-06-12 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2024-05-31 - Kvartalsrapport 2024-Q1
2024-02-27 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-07-03 - Extra Bolagsstämma 2023
2023-06-13 - Årsstämma
2023-05-24 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2022-05-24 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-26 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2021-05-25 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2020-05-26 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-18 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2019-05-22 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Q-Linea är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av instrument och förbrukningsartiklar. Produkterna används huvudsakligen vid behandling av infektionssjukdomar och blodförgiftning, och innefattar diagnostik- och analysverktyg, samt grundläggande provhantering. Tekniken baseras på den så kallade ID- samt AST tekniken. Q-Linea grundades 2008 och har huvudkontor i Uppsala.
2025-10-21 17:00:00

The extraordinary general meeting of Q-linea AB (publ) (the “Company”), org.nr. 556729-0217, was held on October 21, 2025 in Uppsala, Sweden, at which the shareholders primarily resolved as follows. All decisions were made with the majority necessary.

The general meeting was held at Advokatfirman Lindahl’s premises at Vaksalagatan 10 in Uppsala. For more detailed information on the content of the resolutions, please see the complete notice of the extraordinary general meeting that is available on the Company’s website, www.qlinea.com. Minutes from the extraordinary general meeting will be provided on the mentioned website within two weeks from the day of the meeting.

Approval of the board of directors’ resolution on September 18, 2025 to issue new shares with preferential rights for existing shareholders
The general meeting resolved to approve the board of directors' resolution on September 18, 2025to issue new shares with preferential rights for existing shareholders. The resolution entails and increase of the Company’s share capital by a maximum of SEK 1,287,374.60 through a new issue of a maximum of 12,873,746 shares. The right to subscribe for shares shall, with preferential right, belong to those who, on the record date for the rights issue, are recorded as shareholders of the Company. One existing share entitles to two subscription rights, and one subscription right entitles to subscription of one new share. Subscription of shares shall be made during the period from October 27, 2025 to November 10, 2025. The new shares are issued at a subscription price of SEK 25 per share.

If not all new shares are subscribed for with the support of subscription rights, the board of directors shall decide on allotment of new shares without the support of subscription rights in accordance with certain terms and conditions set out in the resolution on the Rights Issue.

Amendments to the articles of association

The general meeting resolved, in accordance with the board of directors' proposal, to amend the articles of association in order to achieve more appropriate limits for the share capital and the number of shares following the completion of the rights issue, whereby the interval for the share capital was changed to a minimum of SEK 1,500,000 and a maximum of SEK 6,000,000 and the interval for the number of shares to a minimum of 15,000,000 and a maximum of 60,000,000 shares.

Authorization for the board of directors to resolve on the issuing of new shares to guarantors

The general meeting authorized the board of directors to, on one or more occasions during the period until the next annual general meeting and with deviation from the shareholders' preferential rights and with or without conditions regarding set-off or other conditions, resolve on the issue of shares as compensation to those who have entered into guarantee commitments in the Rights Issue. Upon exercise of the authorization, the terms and conditions for the shares shall be the same as in the Rights Issue.